Resources

Key Reprints

1990-'94

A Mammalian Cell Cycle Checkpoint Pathway Utilizing p53 and GADD45 is Defective in Ataxia-Telangiectasia

PDF Logo
View File

Definition of a consensus binding site for p53

PDF Logo
View File

1995 - '99

Topological Control of p21WAF1/CIP1 Expression in Normal and Neoplastic Tissues

PDF Logo
View File

Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21

PDF Logo
View File

KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene

PDF Logo
View File

Regulation of p53 downstream genes

PDF Logo
View File

Molecular Cloning and Functional Analysis of the Mouse Homologue of the KILLER/DR5 Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) Death Receptor1

PDF Logo
View File

2000 - '04

Pointing (zinc) fingers at BRCA1 targets

PDF Logo
View File

Repression of BRCA1 through a Feedback Loop Involving p53

PDF Logo
View File

Insights into cancer therapeutic design based on p53 and TRAIL receptor signaling

PDF Logo
View File

Death Domain Mutagenesis of KILLER/DR5 Reveals Residues Critical for Apoptotic Signaling

PDF Logo
View File

Identification of Inhibitors of TRAIL-induced Death (ITIDs) in the TRAIL-sensitive Colon Carcinoma Cell Line SW480 Using a Genetic Approach*

PDF Logo
View File

Tissue-specific Induction of p53 Targets in Vivo1

PDF Logo
View File

The Mutant p53-Conformation Modifying Drug, CP-31398, Can Induce Apoptosis of Human Cancer Cells and Can Stabilize Wild-Type p53 Protein

PDF Logo
View File

BRCA1 Transcriptionally Regulates Damaged DNA Binding Protein (DDB2) in the DNA Repair Response Following UV-Irradiation

PDF Logo
View File

BID regulation by p53 contributes to chemosensitivity

PDF Logo
View File

BRCA1 Directs a Selective p53-Dependent Transcriptional Response towards Growth Arrest and DNA Repair Targets

PDF Logo
View File

Stabilization of p53 by CP-31398 Inhibits Ubiquitination without Altering Phosphorylation at Serine 15 or 20 or MDM2 Binding

PDF Logo
View File

Identification and Characterization of the Cytoplasmic Protein TRAF4 as a p53-regulated Proapoptotic Gene

PDF Logo
View File

Requirement of p53 targets in chemosensitization of colonic carcinoma to death ligand therapy

PDF Logo
View File

Direct Repression of FLIP Expression by c-myc Is a Major Determinant of TRAIL Sensitivity

PDF Logo
View File

Nature’s TRAIL— Minireview On a Path to Cancer Immunotherapy

PDF Logo
View File

The role of p53 in chemosensitivity and radiosensitivity

PDF Logo
View File

Bnip3L is induced by p53 under hypoxia, and its knockdown promotes tumor growth

PDF Logo
View File

Targeting Bcl-xL in esophageal squamous cancer to sensitize to chemotherapy plus TRAIL-induced apoptosis while normal epithelial cells are protected by blockade of caspase 9

PDF Logo
View File

Suppression of caspase-8- and -10-associated RING proteins results in sensitization to death ligands and inhibition of tumor cell growth

PDF Logo
View File

Death Induction by Recombinant Native TRAIL and Its Prevention by a Caspase 9 Inhibitor in Primary Human Esophageal Epithelial Cells

PDF Logo
View File

Inducible Silencing of KILLER/DR5 In vivo Promotes Bioluminescent Colon Tumor Xenograft Growth and Confers Resistance to Chemotherapeutic Agent 5-Fluorouracil

PDF Logo
View File

2005 - '09

DR5 Knockout Mice Are Compromised in Radiation-Induced Apoptosis

PDF Logo
View File

Overview of Cell Death Signaling Pathways

PDF Logo
View File

Meeting Report: The International Conference on Tumor Progression and Therapeutic Resistance

PDF Logo
View File

Distinct Signaling Pathways in TRAIL- versus Tumor Necrosis Factor-Induced Apoptosis

PDF Logo
View File

p73 or p53 Directly Regulates Human p53 Transcription to Maintain Cell Cycle Checkpoints

PDF Logo
View File

Tumorigenic Conversion of Primary Human Esophageal Epithelial Cells Using Oncogene Combinations in the Absence of Exogenous Ras

PDF Logo
View File

Small-molecule modulators of p53 family signaling and antitumor effects in p53-deficient human colon tumor xenografts

PDF Logo
View File

Imaging and Oncologic Drug Development

PDF Logo
View File

Multimodality Optical Imaging and 18F-FDG Uptake in Wild-Type p53-Containing and p53-Null Human Colon Tumor Xenografts

PDF Logo
View File

Cell Cycle–Dependent and Schedule-Dependent Antitumor Effects of Sorafenib Combined with Radiation

PDF Logo
View File

Invincible, but Not Invisible: Imaging Approaches Toward In Vivo Detection of Cancer Stem Cells

PDF Logo
View File

TRAIL-R deficiency in mice promotes susceptibility to chronic inflammation and tumorigenesis

PDF Logo
View File

Reduced cell death, invasive and angiogenic features conferred by BRCA1-deficiency in mammary epithelial cells transformed with H-Ras

PDF Logo
View File

2010 - Current

Overcoming Hypoxia-Induced Apoptotic Resistance through Combinatorial Inhibition of GSK-3 b and CDK1

PDF Logo
View File

High-Resolution Imaging and Antitumor Effects of GFP Bone Marrow-Derived Cells Homing to Syngeneic Mouse Colon Tumors

PDF Logo
View File

Preliminary observations indicate variable patterns of plasma 5-fluorouracil (5-FU) levels during dose optimization of infusional 5-FU in colorectal cancer patients

PDF Logo
View File

Human colon cancer stem cells are enriched by insulin-like growth factor-1 and are sensitive to figitumumab

PDF Logo
View File

Off-Target Lapatinib Activity Sensitizes Colon Cancer Cells Through TRAIL Death Receptor Up-Regulation

PDF Logo
View File

Genetics of Aging and Longevity

PDF Logo
View File

Dual Inactivation of Akt and ERK by TIC10 Signals Foxo3a Nuclear Translocation, TRAIL Gene Induction, and Potent Antitumor Effects

PDF Logo
View File

Quest For Answers
"We're trying to understand how cancer cells die, how they're affected by chemotherapy or newer agents, why they become resistant to certain treatments and how to develop strategies to reverse the resistance," says Wafik El-Deiry, MD, PhD, chief of hematology/oncology at Penn State Hershey Medical Center
View the .entire PDF article

Kuwait Prize In Applied Sciences
Dr. El-Deiry was recognized for his work on tumor suppressor genes including p53 and TRAIL, and mechanisms that determine cancer therapeutic response. Dr. El-Deiry was recognized for developing new strategies targeting cell death for cancer therapy.
Read the full article from Cancer Biology & Therapy

Small Molecule Drug Drives Cancer Cells to Suicide
Cancer researchers have pinned down a molecule that can kick-start the body's own tumour-destroying systems, triggering cell death in cancerous but not healthy tissue in mice.
Read the full article from Nature News